What role can LDN have in a comprehensive pediatric cancer care plan?
Revolutionizing Health: Low Dose Naltrexone and Therapeutic Plasma Exchange – Dr Pamela Smith
Dr. Pamela Smith explores the benefits of low dose naltrexone (LDN) and therapeutic plasma exchange (TPE) for treating toxins and autoimmune diseases. She discusses the rising toxicity in patients and how combining TPE with LDN and nutrients can enhance health outcomes. The importance of personalized treatment plans and the role of inflammation in chronic diseases […]
Low Dose Naltrexone for Autoimmune Diseases
Low Dose Naltrexone for Autoimmune Diseases Written by Johnette Cruz, Published on November 13, 2025 https://wibc.com/780419/low-dose-naltrexone-for-autoimmune-diseases/ BROWNSBURG, IN – A medication long known for its use in substance abuse treatment is getting a second life in the world of functional medicine, offering a new approach for people suffering from chronic autoimmune disorders. In an exclusive […]
Empowering Health: Shanika’s Journey with Autoimmune Diseases
Empowering Health: Shanika’s Journey with Autoimmune Diseases Shanika shares her long journey with autoimmune diseases, beginning with psoriasis in her youth. She highlights the challenges of managing symptoms and the struggle for a proper diagnosis. After years, she is diagnosed with sarcoidosis and finds relief through low dose naltrexone. As an advocate for LDN, […]
LDN: The Anti-Inflammatory and Longevity Potential of Low Dose Naltrexone
LDN: The Anti-Inflammatory and Longevity Potential of Low Dose Naltrexone by The FINANCIAL March 3, 2025 https://finchannel.com/ldn-the-anti-inflammatory-and-longevity-potential-of-low-dose-naltrexone/124870/business-2/2025/03/ Low Dose Naltrexone (LDN) is emerging as a promising tool in longevity science. Originally approved to treat opioid addiction in high doses, researchers have discovered that at lower doses, naltrexone plays a key role in reducing inflammation, modulating […]
Protocol for Vaccine Injury Management
Protocol for Vaccine Injury Management Based on the immune picture revealed by Yale LISTEN study Koolbeens cafe, March 02, 2025 A recent Yale study (preprint) provided a picture of the immune system in post vaccine syndrome (PVS) patients. I have already recorded a video presenting this picture. Sadly, this picture is evidence for an overstimulated […]
Kris has shared her journey with LDN (Low Dose Naltrexone) and MCAS (Mast Cell Activation Syndrome) with us.
Kris has generously shared her personal journey with Low Dose Naltrexone (LDN), a medication used to treat a variety of conditions, including autoimmune diseases, and MCAS, a condition where mast cells release excessive amounts of histamine and other chemicals, causing an array of symptoms such as hives, itching, and digestive problems. In her story, Kris […]
AgelessRx Reports Promising Results from LDN Quality of Life Study for Healthy Aging
Digital Journal.com AgelessRx Reports Promising Results from LDN Quality of Life Study for Healthy Aging PRESS RELEASE Published August 30, 2024 Ann Arbor, MI – AgelessRx, a leading online telehealth platform specializing in longevity science, is proud to announce promising results from their recent study on Low Dose Naltrexone (LDN) for Quality of Life (QoL) […]
Current pharmacotherapeutic properties of low-dose naltrexone therapy in humans and possible therapeutic and prophylactic indications in cats and dogs
Reza G. Marangaloo et al., German Journal of Veterinary Research, 20th February 2024 https://gmpc-akademie.de/articles/1709702482_2024_4_1_0070_GJVR_Marangaloo.pdf Abstract Naltrexone was first developed in 1963 as an opioid antagonist for therapeutic use in opioid-dependent individuals (alcohol, narcotics, and tobacco) with a 50 mg/day dose approved by the Food and Drug Administration (FDA). In 1985, Dr. Bernard Bihari explained that when […]